-
Loading metrics
Cost-Utility Analysis of Lopinavir/Ritonavir versus Atazanavir + Ritonavir Administered as First-Line Therapy for the Treatment of HIV Infection in Italy: From Randomised Trial to Real World
- Emanuela Foglia,
- Paolo Bonfanti,
- Giuliano Rizzardini,
- Erminio Bonizzoni,
- Umberto Restelli,
- Elena Ricci,
- Emanuele Porazzi,
- Francesca Scolari,
- Davide Croce
x
- Published: February 27, 2013
- https://doi.org/10.1371/journal.pone.0057777